Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis

Autor: Patrizia Künzler-Heule, Sandra Engberg, Manuel Battegay, Axel J. Schmidt, Katharina Fierz, Huyen Nguyen, Agnes Kocher, Christiana Nöstlinger, Benjamin Hampel, Marcel Stöckle, Charles Béguelin, Julie Delaloye, Patrick Schmid, Markus Flepp, Mathieu Rougement, Dominique Laurent Braun, Jan Fehr, Dunja Nicca, the Swiss HIV Cohort Study (SHCS)

Publikováno v: BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)

Abstract Background Hepatitis C virus (HCV) is common in men who have sex with men (MSM) with HIV. The Swiss HCVree Trial targeted a micro-elimination by using a treat and counsel strategy. Self-reported condomless anal intercourse with non-steady pa

Externí odkaz: https://doaj.org/article/b36916d5b366426cb53fc667589f8096

Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis [version 2; peer review: 3 approved]

Autor: Gilles Wandeler, Marta Buzzi, Nanina Anderegg, Delphine Sculier, Charles Béguelin, Matthias Egger, Alexandra Calmy

Publikováno v: F1000Research, Vol 7 (2019)

Background: Dolutegravir-containing maintenance therapy is a promising simplification strategy for virologically suppressed HIV-infected individuals. However, most of the available data to inform this strategy come from small, uncontrolled studies. W

Externí odkaz: https://doaj.org/article/ebd1133b443c41c0a2511525d0058757

Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis [version 1; referees: 3 approved]

Autor: Gilles Wandeler, Marta Buzzi, Nanina Anderegg, Delphine Sculier, Charles Béguelin, Matthias Egger, Alexandra Calmy

Publikováno v: F1000Research, Vol 7 (2018)

Background: Dolutegravir-containing maintenance therapy is a promising simplification strategy for virologically suppressed HIV-infected individuals. However, most of the available data to inform this strategy come from small, uncontrolled studies. W

Externí odkaz: https://doaj.org/article/5271c1caed614fc4be8728764be94cfa

HBV REPLICATION DURING TENOFOVIR THERAPY IS FREQUENT IN HIV/HBV-COINFECTION

Autor: Eveline, Hofmann, Bernard, Surial, Noémie, Boillat-Blanco, Huldrych F, Günthard, Marcel, Stöckle, Enos, Bernasconi, Patrick, Schmid, Alexandra, Calmy, Franziska, Suter-Riniker, Andri, Rauch, Gilles, Wandeler, Charles, Béguelin

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In the Swiss HIV Cohort Study, 61/222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after two years on tenofovir, of whom 77% were suppressed thereafter. Self-reported adherence to therapy and HBV vir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9abbabdf2597556ee59356e29b13349a
https://pubmed.ncbi.nlm.nih.gov/36242550

Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program

Autor: Katharina, Kusejko, Luisa, Salazar-Vizcaya, Cyril, Shah, Marcel, Stöckle, Charles, Béguelin, Patrick, Schmid, Marie, Ongaro, Katherine, Darling, Enos, Bernasconi, Andri, Rauch, Roger D, Kouyos, Huldrych F, Günthard, Jürg, Böni, Jan S, Fehr, Dominique L, Braun, S, Yerly

Publikováno v: Kusejko, Katharina; Salazar-Vizcaya, Luisa; Shah, Cyril; Stöckle, Marcel; Béguelin, Charles; Schmid, Patrick; Ongaro, Marie; Darling, Katherine; Bernasconi, Enos; Rauch, Andri; Kouyos, Roger D; Günthard, Huldrych F; Böni, Jürg; Fehr, Jan S; Braun, Dominique L (2022). Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program. Clinical infectious diseases, 75(10), pp. 1723-1731. Oxford University Press 10.1093/cid/ciac273

Background The Swiss HCVree Trial (NCT 02785666) was conducted in 2015–2017 with the goal of implementing a population-based systematic hepatitis C virus (HCV) micro-elimination program among men who have sex with men (MSM) with human immunodeficie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3076f679c0dc161111c7ac8a6ea96f5e
https://pubmed.ncbi.nlm.nih.gov/35404384